The aim of the study was to determine whether it is possible to differentiate submucosal fibroids before interventional procedures based on mean platelet volume (MPV), in reproductive-age patients presenting with endometrial thickening and abnormal uterine bleeding.
Introduction
Abnormal uterine bleeding (AUB) is one of the most common reason of outpatient gynecologic visits and a very frequent gynecological complaint in the reproductive age group. It is referred as excessive bleeding at any time or bleeding outside the normal menstrual cycle and constitutes a major clinical indication for hysterectomy. 1 Diagnostic procedures included transvaginal sonography, pelvic examination and a detailed medical history. 2 In patients 35 years and older presenting with endometrial thickening ≥12 mm, endometrial biopsy is the most effective way to confirm the pathological diagnosis. 3 In recent years hysteroscopic evaluation is the gold standard in AUB as it gives the chance of direct visualization of the endometrial pathologies and guided biopsy of any local lesion. [4] [5] [6] But in terms of accessibility and cost effectiveness endometrial curettage is still preferred by clinicians as the initial diagnostic tool.
The diagnostic value of complete blood count such as, mean platelet volume (MPV), neutrophil to lymphocyte ratio (NLR) and platelet to lymphocyte ratio (PLR) parameters has been the subject of many studies in gynecology and gynecological oncology. 7, 8 In the case of uterine fibroids or leiomyomas, the increased expression of erythropoietin (EPO) and platelet-derived growth factor A (PDGF-A) within the growths may influence CBC parameters in a diagnostically significant manner. This is because EPO and PDGF-A both promote the development of uterine smooth muscle cells, thereby promoting growth of the leiomyoma and release of platelets from the bone marrow and thus eliciting a decrease in mean platelet volume (MPV). 9, 10 The aim of this study was to investigate the diagnostic value of platelet counts and MPV data in distinguishing the presence of submucosal leiomyomas. Such information is useful in the selection or planning of invasive procedures, such as hysteroscopy or curettage, among patients who have increased endometrial thickness and abnormal uterine bleeding.
Material and Method
This retrospective study was based on the review of medical files from 6,278 patients presenting with menstrual irregularities who then underwent diagnostic procedures at the gynecology clinic of a tertiary referral hospital. Written informed consent was obtained from all participants. The protocol was approved by the Hospital and the Ethics Committee of the Kanuni Sultan Süleyman Training and Research Hospital in accordance with the Declaration of Helsinki. The files of patients were evaluated and the information about age, gravida, parity, body mass index, complete blood count and pathology parameters were revealed. Curettage applied by carmen cannula was used as a diagnostic approach. Operative hysteroscopy was carried out using a 5 mm Karl-Storz optics. After expanding the uterine cavity by infusion of saline, hysteroscopically guided biopsies were taken with 5F semi-rigid biopsy forceps. Patients with systemic disease (hepatic, renal, cardiac), patients with a history of drug use (anticoagulants, nonsteroidal anti-inflammatory drugs, oral contraceptives) or anemia and malignancy that can affect platelet count and MPV values were excluded. The pathology findings showed that 438 patients showed benign endometrial pathology (endometrial thickening due to the effects of estrogen/progesterone, chronic endometritis); these individuals were designated as group 1 (control). In contrast, 143 patients had submucosal fibroid(s) and were designated as group 2. The groups were compared according to whole blood parameters. Because it is difficult to distinguish endometrial polyps from submucosal fibroids due to their polypoid appearance, individuals with endometrial polyps were not included in the control group.
Statistical analyzes were performed using SPSS for Windows 15.0 computer software (Statistical Package for Social Sciences, Chicago, IL, USA). Parameters were expressed as mean and standard deviation. Independent sample ttest was used to compare groups in terms of study parameters. ROC analyzes were performed to assess the diagnostic accuracy and to determine the optimal cut-off value of MPV. P values less than 0.05 were considered statistically significant.
Results
The control group included those with benign endometrial pathology (Group 1, n=438) , and the second group consisted of those with submucosal leiomyomas (Group 2, n=143) . The groups were similar according to demographic characteristics such as age, gravida, parity, body mass index and complete blood count parameters such as hemoglobin levels and white blood count (p>0,05). However, platelet counts were significantly higher and MPV values significantly lower in group 2 patients compared with group 1 control subjects (p=0,001) ( Table I ). In the ROC curve analysis of MPV data, a cut-off value of 8.15 was identified, and the area under the curve (AUC) was found to be 0.611. Sensitivity, specificity, positive predictive value and negative predictive values were found to be 71%, 61%, 67%, 65%, respectively. The analysis of ROC curve was shown in Figure 1 . 
Figure 1: ROC curve analysis of Mean Platelet Volume

Discussion
Myoma uteri is considered to be the most common uterine pathology in reproductive age women. 11 Specifically, we found that platelet counts are higher and MPV values are lower among patients with submucosal fibroids compared with patients with endometrial thickening due to other causes. These results are consistent with previous studies showing that increased EPO secretion from leiomyomas promotes the release of precursor materials from the bone marrow. In addition, Asano et al. demonstrated that leiomyoma-derived EPO promotes the acceleration of tumor growth. 12 Wolf et al. and McDonald et al. showed a significant increase in platelet production in animals receiving EPO. 13, 14 It has also shown in another study that uterine fibroids secrete PDGF-C, which subsequently promotes the growth of smooth muscle cells of the uterus and uterine fibroids. 10 In addition, PDGF-C promotes platelet release from the bone marrow. 9 Thus, as such reasons may influence the platelet counts and MPV levels in patients with submucosal fibroids, both platelet count and MPV data collected during the course of standard CBC analysis may provide useful diagnostic information in patients suffering from endometrial thickening and abnormal bleeding of unknown etiology.
Benign endometrial changes are the most common observed pathological findings in the endometrial samplings of reproductive-age women with abnormal uterine bleeding. However, endometrial polyps, endometrial hyperplasia, and submucosal fibroids are also frequently encountered. 15, 16 In recent years, the number of diagnostic tests in clinical practice has increased rapidly. The sensitivity of transvaginal ultrasound which is a practical method for the detection of endometrial pathologies, is reported as 50% and the specificity as 90% . 17 However, the unsuccessful diagnostic role of TV ultrasound in endometrial pathologies is also shown by many studies. 18, 19 Failure to diagnose with the ultrasonography results directs gynecologists to invasive procedures and raises the need for pathological diagnosis.
Patients admitted with abnormal bleeding who show increased endometrial thickness (>12 mm) and irregularity are often referred for invasive diagnostic procedures such as curettage, saline infusion sonography (SIS) and hysteroscopy instead of ultrasound. Especially in patients with a suspected diagnosis of submucosal fibroids or endometrial polyps, the success of hysteroscopy on the diagnosis has been shown to be between 53-97%. 20, 21 Hysteroscopic myomectomy should be considered firstline conservative surgical therapy for the management of symptomatic submucosal myomas. 22 It is highly effective in resolving abnormal bleeding, with a success rate between 70-90%. In addition, it reverses the negative impacts of submucosal fibroids on fertility (both in the case of spontaneous fertility and in assisted reproduction technologies). However, due to the lack of equipment, invasiveness of the procedure, and cost, hysteroscopy is typically not the preferred modality of treatment, and physicians may instead opt for fractional curettage. However, for both of these procedures, knowledge of fibroid characteristics prior to surgery helps to select the appropriate treatment, as well as to ensure that the appropriate instruments and surgical expertise are in place.
Patients who are admitted with abnormal uterine bleeding but do not show the pathognomonic characteristics of a submucosal fibroid or a polyp on transvaginal sonography may be candidates for more invasive procedures such as curettage or hysteroscopy. The use of platelet counts and MPV as diagnostic tools may help reduce the use of invasive procedures when they are not required or to select the most appropriate invasive procedure for follow-up. Because of its accessibility, simplicity, low cost, and high sensitivity, MPV may be a highly valuable tool in distinguishing submucosal fibroids from other causes of abnormal uterine bleeding. However, additional larger prospective studies are required to confirm these findings and to clarify a rigorous diagnostic guideline.
